Kobatake K, Goto K, Sakamoto Y, Iwane K, et al. Influence of best objective response to first-line treatment on survival outcomes in advanced urothelial carcinoma in the era of sequential therapy with enfortumab vedotin. Int J Urol 2025;32:524-530.
PMID: 39930593